The prostate: Diagnostic evaluation of metastatic disease

Radiologic Clinics of North America

Volumn 38, Issue 1, 2000, Pages 139-157

  Yu, Kyle K ^a   Hawkins, Randall A ^a,b  

^a Department of Radiology ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BONE METASTASIS; BONE SCINTISCANNING; CANCER RECURRENCE; CANCER STAGING; CANCER THERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; LYMPH NODE METASTASIS; LYMPHANGIOGRAPHY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SCINTIGRAPHY; TREATMENT CONTRAINDICATION;

EID: 0033958595     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-8389(05)70153-6     Document Type: Article

References (57)

1. M. Alagiri M.D. Colton E.J. Seidmon The staging pelvic lymphadenectomy: Implications as an adjunctive procedure for clinically localized prostate cancer Br J Urol 80 1997 243
2. F.H. Amo F. Verdu Tartajo J.M. Diez Cordero Reliability of CT for determining lymphatic involvement in patients with prostate cancer Arch Esp Urol 50 1997 464
3. J.S. Apple D.F. Paulson C. Baber C.E. Putman Advanced prostatic carcinoma: Pulmonary manifestations Radiology 154 1985 601
4. R.J. Babaian J. Sayer D.A. Podoloff Radioimmunoscintigraphy of pelvic lymph nodes with 111 indium-labeled monoclonal antibody CYT-356 J Urol 152 6 pt 1 1994 1952
5. H. Bender A. Schomburg P. Albers Possible role of FDG-PET in the evaluation of urologic malignancies Anticancer Res 17 1997 1655
6. J.K. Burgers G.H. Hinkle M.K. Haseman Monoclonal antibody imaging of recurrent and metastatic prostate cancer Semin Urol 13 1995 103
7. P.J. Effert R. Bares S. Handt Metabolic imaging of untreated prostate cancer by positron emission tomography with 18 fluorine-labeled deoxyglucose J Urol 155 1996 994
8. J.I. Epstein M.J. Carmichael G. Pizov P.C. Walsh Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term followup J Urol 150 1993 135
9. M.R. Feneley V.U. Chengazi R.S. Kirby Prostatic radioimmunoscintigraphy: Preliminary results using technetium-labelled monoclonal antibody, CYT-351 Br J Urol 77 1996 373
10. H.P. Forman L.A. Fox H.S. Glazer Chest radiography in patients with early stage prostatic carcinoma. Effect on treatment planning and cost analysis Chest 106 1994 1036
11. H.P. Forman J.P. Heiken J.A. Brink CT screening for comorbid disease in patients with prostatic carcinoma: Is it cost-effective? AJR Am J Roentgenol 162 1994 1125
12. Y. Fujii Y. Higashi F. Owada Magnetic resonance imaging for the diagnosis of prostate cancer metastatic to bone Br J Urol 75 1995 54
13. M.E. Gleave D. Coupland D. Drachenberg Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer Urology 47 1996 708
14. M. Golimbu P. Morales S. Al-Askari Y. Shulman CAT scanning in staging of prostatic cancer Urology 18 1981 305
15. J.H. Gothlin L. Hoiem Percutaneous fine needle biopsy of radiographically normal lymph nodes in the staging of prostatic cancer Radiology 141 1981 351
16. M. Grijalba Uche J.F. Bonaut Mendia Metastases to the temporal bone. A report of two cases Acta Otorrinolaringol Esp 46 1995 441
17. T. Hayashi K. Igarashi A. Tanizawa Brain metastasis as a sole recurrence of prostate cancer after total prostatectomy Urol Int 60 1998 121
18. G.H. Hinkle J.K. Burgers C.E. Neal Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide Cancer 83 1998 739
19. G.H. Hinkle J.K. Burgers J.O. Olsen Prostate cancer abdominal metastases detected with indium-111 capromab pendetide J Nucl Med 39 1998 650
20. C.K. Hoh C. Schiepers M.A. Seltzer PET in oncology: Will it replace the other modalities? Semin Nucl Med 27 1997 94
21. C.K. Hoh M.A. Seltzer J. Franklin Positron emission tomography in urological oncology J Urol 159 1998 347
22. M. Huncharek J. Muscat Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer Abdom Imaging 21 1996 364
23. G.J. Jager J.O. Barentsz G.O. Oosterhof Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence AJR Am J Roentgenol 167 1996 1503
24. D. Kahn R.D. Williams M.K. Haseman Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy J Clin Oncol 16 1998 284
25. D. Kahn R.D. Williams M.J. Manyak 111 Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group J Urol 159 1998 2041
26. P.M. Kemp G.A. Maguire N.J. Bird Which patients with prostatic carcinoma require a staging bone scan? Br J Urol 79 1997 611
27. B.C. Lentle D.G. McGowan H. Dierich Technetium-99m polyphosphate bone scanning in carcinoma of the prostate Br J Urol 46 1974 543
28. P.E. Levesque P.T. Nieh L.N. Zinman Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy Urology 51 1998 978
29. Z. Levran J.A. Gonzalez A.C. Diokno Are pelvic computed tomography, bone scan and pelvic lymphadenectomy necessary in the staging of prostatic cancer? Br J Urol 75 1995 778
30. M.M. Lindell L.C. Doubleday A.C. VonEschenback H.I. Libshitz Mediastinal metastases from prostatic carcinoma J Urol 128 1982 331
31. A.P. McLaughlin S.L. Saltzstein D.L. McCullough R.F. Gittes Prostatic carcinoma: Incidence and location of unsuspected lymphatic metastases J Urol 115 1976 89
32. J.E. Montie Follow-up after radical prostatectomy or radiation therapy for prostate cancer Urol Clin North Am 21 1994 673
33. C. Morgan R.F. Calkins E.J. Cavalcanti Computed tomography in the evaluation, staging, and therapy of carcinoma of the bladder and prostate Radiology 140 1981 751
34. J.E. Oesterling S.K. Martin E.J. Bergstralh F.C. Lowe The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer JAMA 269 1993 57
35. K. Ohmori H. Matsui T. Yasuda Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams Jpn J Clin Oncol 27 1997 263
36. M. Ohori P.T. Scardino S.L. Lapin The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer Am J Surg Pathol 17 1993 1252
37. R.H. Oyen H.P. Van Poppel F.E. Ameye Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: Prospective study of 285 patients Radiology 190 1994 315
38. A.W. Partin M.W. Kattan E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445
39. D.F. Paulson The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma J Urol 121 1979 300
40. C.A. Perez Carcinoma of the prostate: A model for management under impending health care system reform. 1994 RSNA annual oration in radiation oncology Radiology 196 1995 309
41. B. Planz P. Szyska M. Valdor Detection of circulating prostatic cells during radical prostatectomy Urol Res 25 1997 385
42. J.E. Pontes B. Choe N. Rose J.M. Pierce Jr Reliability of bone marrow acid phosphatase as a parameter of metastatic prostatic cancer J Urol 122 1979 178
43. G.R. Prout Jr J.A. Heaney P.P. Griffin Nodal involvement as a prognostic indicator in patients with prostatic carcinoma J Urol 124 1980 226
44. J. Rorvik O.J. Halvorsen G. Albrektsen S. Haukaas Lymphangiography combined with biopsy and computer tomography to detect lymph node metastases in localized prostate cancer Scand J Urol Nephrol 32 1998 116
45. F.H. Schroder P. Hermanek L. Denis The TNM classification of prostate cancer Prostate Suppl 4 1992 129
46. L.H. Schwartz L.R. LaTrenta E. Bonaccio Small cell and anaplastic prostate cancer: Correlation between CT findings and prostate-specific antigen level Radiology 208 1998 735
47. P.D. Shreve H.B. Grossman M.D. Gross R.L. Wahl Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose Radiology 199 1996 751
48. D.B. Sodee R. Conant M. Chalfant Preliminary imaging results using In-111 labeled CYT-356 (ProstaScint) in the detection of recurrent prostate cancer Clin Nucl Med 21 1996 759
49. J. Spencer S. Golding CT evaluation of lymph node status at presentation of prostatic carcinoma Br J Radiol 65 1992 199
50. J.A. Spencer S.J. Golding Patterns of lymphatic metastases at recurrence of prostate cancer: CT findings Clin Radiol 49 1994 404
51. P. Suarez L. Mondes N. Bernardo Correlation between computed axial tomography and ileum obturating lymphadenectomy in localized adenocarcinoma of the prostate Arch Esp Urol 50 1997 131
52. P. Vassallo C. Matei W.D. Heston Characterization of reactive versus tumor-bearing lymph nodes with interstitial magnetic resonance lymphography in an animal model Invest Radiol 30 1995 706
53. M. Weckesser V.G. Muller-Mattheis H. Vosberg H.W. Muller-Gartner Pathogenetic differentiation of the bone superscan using bone marrow scintigraphy Nuklearmedizin 37 1998 156
54. P.M. Weinerman P.H. Arger B.G. Coleman Pelvic adenopathy from bladder and prostate carcinoma: Detection by rapid sequence computed tomography AJR Am J Roentgenol 140 1983 95
55. W.J. Whitemore Jr Natural history and staging of prostate cancer Urol Clin North Am 11 1984 209
56. J.S. Wolf Jr M. Cher M. Dall'era The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy J Urol 153 3 pt 2 1995 993
57. K. Yoshida M. Akimoto Computed tomographic evaluation of bone metastases in prostatic cancer patients Adv Exp Med Biol 324 1992 197